EAGLE PHARMACEUTICALS, INC.

8-K

Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing

15 Nov 24

NT 10-Q

Notification Of Inability To Timely File Form 10-q.

13 Nov 24

8-K

Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits

12 Nov 24

8-K

Entry Into A Material Definitive Agreement, Material Modifications To Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Regulation Fd Disclosure, Financial Statements And Exhibits

31 Oct 24

8-K

Results Of Operations And Financial Condition, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Non-reliance On Previously Issued Financial Statements Or A Related Audit Report Or Completed Interim Review, Other Events

02 Oct 24

8-K

Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Off-balance Sheet Arrangement Of A Registrant, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Regulation Fd Disclosure, Financial Statements And Exhibits

27 Aug 24

NT 10-Q

Notification Of Inability To Timely File Form 10-q.

09 Aug 24

8-K

Other Events

05 Aug 24

8-K

Entry Into A Material Definitive Agreement

10 Jul 24

8-K

Other Events

29 May 24

8-K

Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Regulation Fd Disclosure, Financial Statements And Exhibits

22 May 24

8-K

Entry Into A Material Definitive Agreement, Financial Statements And Exhibits

15 May 24

NT 10-Q

Notification Of Inability To Timely File Form 10-q.

10 May 24

8-K

Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Regulation Fd Disclosure, Financial Statements And Exhibits

12 Apr 24

NT 10-K

Notification Of Late Filing Of Annual 10-k Report.

18 Mar 24

8-K

Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits

08 Mar 24

8-K

Entry Into A Material Definitive Agreement, Financial Statements And Exhibits

01 Mar 24

8-K

Cost Associated With Exit Or Disposal Activities

29 Feb 24

8-K

Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits

29 Nov 23

8-K

Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Regulation Fd Disclosure, Financial Statements And Exhibits

29 Nov 23

Eagle Pharmaceuticals, Inc.

Latest Filings – Non-Ownership

Latest Filings – Ownership

Latest Filings – Ownership

Latest Filings – Non-Ownership